# Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers

> **NCT01083095** · EARLY_PHASE1 · COMPLETED · sponsor: **Malaria Vaccine and Drug Development Center** · enrollment: 18 (actual)

## Conditions studied

- Malaria, Vivax

## Interventions

- **BIOLOGICAL:** Sporozoite Challenge Model for Plasmodium vivax in Humans

## Key facts

- **NCT ID:** NCT01083095
- **Lead sponsor:** Malaria Vaccine and Drug Development Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-03
- **Final completion:** 2006-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2010-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083095, "Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01083095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*